This is a standard sponsor 13D filed after a SPAC IPO. No activist campaign or governance challenge is present. Monitor for the initial business combination announcement, which will trigger the forward purchase agreement and conversion of Class B shares.
Price Chart
Executive Summary
Frazier Life Sciences Holdings II LLC (the sponsor) filed a Schedule 13D disclosing beneficial ownership of 1,983,749 ordinary shares (20.5%) of Frazier Life Sciences Acquisition Corp. II, a blank-check SPAC. The filing is a routine post-IPO disclosure of sponsor and insider holdings, with no activist intent or demands for change.
Key Financial Metrics
Key Facts
- Sponsor holds 1,983,749 ordinary shares (300,000 Class A + 1,683,749 Class B), representing 20.5% of 9,675,000 outstanding shares post-IPO
- Sponsor acquired 300,000 Class A private placement shares at $10.00/share for $3,000,000 total
- Sponsor originally held 2,156,250 Class B shares acquired for $25,000; transferred 195,190 to directors/officers and forfeited 277,311
- Frazier Life Sciences Public Fund committed to purchase minimum 2,500,000 Class A shares ($25,000,000) at business combination closing via Forward Purchase Agreement
- Reporting persons reserve right to acquire or dispose of additional shares; no current plans for board changes, mergers, or other extraordinary actions
Financial Impact
Sponsor holds 20.5% stake; private placement of $3,000,000 at $10.00/share; forward purchase commitment of $25,000,000
Risk Factors
- SPAC may fail to identify or complete a qualifying business combination within required timeframe
- Forward purchase agreement creates downside protection but also potential for forced liquidation if no deal closes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D Filing (Primary) | 0001193125-26-428005 |
| Document: 0001193125-26-428005-index.html | 0001193125-26-428005 |
| Document: 0001193125-26-428005.txt | 0001193125-26-428005 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $10.27 | awaiting T+5 | — | $10.30 (+0.29%) |
Oct 22, 2026 3d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.30 (+0.29%) |
Oct 21, 2026 4d ago | SC 13D | $10.27 | awaiting T+5 | — | $10.30 (+0.29%) |
Oct 21, 2026 4d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.30 (+0.29%) |
Oct 21, 2026 4d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.30 (+0.29%) |
Oct 16, 2026 10d ago | SC 13G | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.30 (−0.48%) |
Oct 15, 2026 10d ago | Insider Buy | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.30 (−0.48%) |
Oct 15, 2026 10d ago | 8-K | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.30 (−0.48%) |
Oct 14, 2026 11d ago | 424B4 | $10.49 $10.27 | ▼ −2.10% | ▼ −1.08% | $10.30 (−1.81%) |
Oct 14, 2026 12d ago | EFFECT | $10.29 $10.30 | ▲ +0.10% | ▼ −0.36% | $10.30 (+0.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers